Statement of Principles concerning malignant neoplasm of the eye No. 64 of 1999

Administered by Department of Veterans' Affairs

Legislation au F2008B00697 Not in force Legislative Instrument

Legislation content

Instrument No.64 of 1999

 

Determination

of

Statement of Principles

concerning

MALIGNANT NEOPLASM OF THE EYE

 

ICD-10-AM CODE: C69.0-C69.4, C69.8

 

Veterans’ Entitlements Act 1986

 

 

1. This Statement of Principles is determined by the Repatriation Medical Authority under subsection 196B(2) of the Veterans’ Entitlements Act 1986 (the Act).

 

Kind of injury, disease or death

2. (a) This Statement of Principles is about malignant neoplasm of the eye and death from malignant neoplasm of the eye.

 

(b) For the purposes of this Statement of Principles,

 

“malignant neoplasm of the eye” means a primary malignant neoplasm of the cells of the eye, attracting an ICD-10-AM code in the range C69.0 to C69.4, or C69.8, but excluding soft tissue sarcoma, non-Hodgkin’s lymphoma and Hodgkin’s disease of or affecting the eye.  The eye means the conjunctiva, cornea, retina, uveal tract (choroid, ciliary body and iris) and eye ball, but excludes lacrimal gland and duct, orbit, optic nerve and the skin and connective tissue of the eyelid.

 

Basis for determining the factors

3. The Repatriation Medical Authority is of the view that there is sound medical-scientific evidence that indicates that malignant neoplasm of the eye and death from malignant neoplasm of the eye can be related to relevant service rendered by veterans, members of Peacekeeping Forces, or members of the Forces.

 

Factors that must be related to service

4. Subject to clause 6, at least one of the factors set out in clause 5 must be related to any relevant service rendered by the person.

 

Factors

5. The factors that must as a minimum exist before it can be said that a reasonable hypothesis has been raised connecting malignant neoplasm of the eye or death from malignant neoplasm of the eye with the circumstances of a person’s relevant service are :

 

(a) having a solar UV damage factor ratio of at least 1.1 before the clinical onset of malignant neoplasm of the eye; or

 

(b) being infected with Human Immunodeficiency Virus (HIV) before the clinical onset of malignant neoplasm of the eye; or

 

(c) inability to obtain appropriate clinical management for malignant neoplasm of the eye.

 

Factors that apply only to material contribution or aggravation

6. Paragraph 5(c) applies only to material contribution to, or aggravation of, malignant neoplasm of the eye where the person’s malignant neoplasm of the eye was suffered or contracted before or during (but not arising out of) the person’s relevant service; paragraph 8(1)(e), 9(1)(e), 70(5)(d) or 70(5A)(d) of the Act refers.

 

Inclusion of Statements of Principles

7. In this Statement of Principles if a relevant factor applies and that factor includes an injury or disease in respect of which there is a Statement of Principles then the factors in that last mentioned Statement of Principles apply in accordance with the terms of that Statement of Principles.

 

Other definitions

8. For the purposes of this Statement of Principles:

 

“being infected with Human Immunodeficiency Virus (HIV)” means serological evidence of infection with Human Immunodeficiency Virus;

 

“death from malignant neoplasm of the eye” in relation to a person includes death from a terminal event or condition that was contributed to by the person’s malignant neoplasm of the eye;

 

“ICD-10-AM code” means a number assigned to a particular kind of injury or disease in The International Statistical Classification of Diseases and Related Health Problems, 10th revision, Australian Modification (ICD-10-AM), effective date of 1 July 1998, copyrighted by the National Centre for Classification in Health, Sydney, NSW, and having ISBN 1 86451 340 3;

 

“relevant service” means:

 

(a) operational service; or

(b) peacekeeping service; or

(c) hazardous service;

 

“solar UV damage factor ratio” means the value obtained by applying the solar UV damage factor ratio formula which is:

 

total lifetime UV damage factor

non-service UV damage factor

 

where:

 

“total lifetime UV damage factor” means the numerical value calculated by the formula:

 

 T

 [MED cum (a,T)] -1  .  PAE (n,M,a) at age (T-t)  . t-

 t-0

 

for the person’s entire life, and where:

 

 has the value of five and is a numerical constant associated with the age dependence of the cumulative incidence;

 

 has the value of two and is a biological amplification factor;

 

“a” is an anatomical body site;

 

“M” is a specified month of the year;

 

“MED” means minimal erythemal dose, where one MED is equal to 200 Joules of radiation per square metre of skin;

 

“[MED cum (a,T)]” is the cumulative solar UV dose to the skin for any given anatomical body site for the person’s age at the time of the assessment;

“n” has the value specified in column 2 of Table 1 opposite the item in column 1 of that Table for each of the specified life activities set out in column 1:

 

Table 1—specified life activities

column 1

column 2

Service workday

1

Service weekend

2

Service recreation period one

3

Service recreation period two

4

Civilian workday

5

Civilian weekend

6

Civilian recreation period one

7

Civilian recreation period two

8

 

“PAE” means personal ambient exposure in MEDs, calculated for each and every month of a person’s life based on an estimate of a typical month during each of the five year periods between the ages of 0 and 20 years and each of the ten year periods thereafter;

 

“PAE (n,M,a)”means the number calculated by the formula:

 

n-8

 MAE (M,Ln) . ABFa . EFn . TRFn . ESFn . CPFn . ERFn . Wn

n-1

 

where:

 

“ABFa  is the anatomical body factor, and has the value specified in column 2 of Table 2 opposite the item in column 1 of that Table for each of the various body sites set out in column 1:

 

Table 2—body site

column 1

column 2

Face

0.15

 

“CPFn  is the clothing protection factor, and has the value assigned to a particular anatomical site proportionately according to the amount of protection provided by clothing and sun screen, ranging from a value of 1.00 for no protection to a value of 0.05 for full cover with heavy clothing for a given specified life activity in column 1 of Table 1;


“EFn is the exposure factor, and has the value specified in column 2 of Table 3 opposite the item in column 1 of that Table for different exposure situations set out in column 1:

 

Table 3—exposure situations

column 1

column 2

Indoor

0.10

Mainly indoor

0.20

Indoor and outdoor

0.35

Mainly outdoor

0.50

Outdoor

0.60

 

“ERFn” is the environment reflectance factor, and has the value specified in column 2 of Table 4 opposite the item in column 1 of that Table for the different environment types set out in column 1:

Table 4—environment types

column 1

column 2

Urban

0.95

Rural

1.00

Maritime

1.00

 

where:

 

“Urban” means a location that is either a city or a town;

 

“Rural” means a location that is bushland, pastoral, or agricultural setting;

 

“Maritime” means either on the sea, lake, major river, or directly adjacent to such a body of water;

 

“ESFn  is the environment shade factor, and has the value specified in column 2 of Table 5 opposite the item in column 1 of that Table for the different environment shade types set out in column 1:

 

Table 5—environment shade types

column 1

column 2

Dense shade

0.50

Moderate shade

0.70

Light shade

0.90

No shade

1.00

 

where:

  

“Dense shade” means a location that is predominantly under dense shade, such as jungle or dense forest;

 

“Moderate shade” means a location that is predominantly under moderate shade, such as open forest or high density housing;

 

“Light shade” means a location that is predominantly under light shade, such as lightly timbered country or low density housing;

 

“No shade”  means a location that is predominantly without shade, such as open fields, tundra, beach, or ocean;

 

“MAE(M,Ln)” is the average daily ambient exposure for month, M, in location, L, assuming a long term average cloud cover, being the value, obtained from the Table set out in Schedule 1, that is contained in the row that corresponds to the particular latitude (rounded to the nearest five degrees) and is contained in the column that corresponds to the month of the year that is the particular month under consideration, for each specified life activity;

 

“TRFn  is the terrain reflectance factor, and has the value specified in column 2 of Table 6 opposite the item in column 1 of that Table for the different terrain types set out in column 1:

 

Table 6—terrain types

column 1

column 2

Brown

1.02

Black 

1.04

Green

1.05

Open water

1.08

Sand

1.16

Snow

1.40

 

where:

 

“Black”  means a terrain predominantly of black material such as asphalt;

 

“Brown” means a terrain predominantly of bare soil, clay, or buildings;

 

“Green” means a terrain predominantly of green vegetation;

 

“Open Water” means an environment surrounded by water;

 

“Sand” means a terrain predominantly of light material such as white or yellow sand;

 

“Snow” means a terrain that is predominantly covered in snow;

 

“Wn is an estimate of the number of days in a month in which a specified life activity in column 1 of Table 1 is performed, and where, for the purposes of this definition, every month is taken to have 30.4375 days;

 

“t” is the age in months of the person for the particular specified activity;

 

“T” is the age in months of the person at the time of assessment;

 

and,

 

“non-service UV damage factor” means the numerical value calculated by the formula:

 

 T

 [MED cum (a,T)] -1  .  PAE (n,M,a) at age (T-t)  . t-

 t-0

 

for the person’s entire life, with the PAE for each month of the person’s period or periods of relevant service being the arithmetic mean of the PAE for each and every month of the person’s life, other than the period or periods of relevant service, where:

 

 has the value of five and is a numerical constant associated with the age dependence of the cumulative incidence;

 

 has the value of two and is a biological amplification factor;

 

“a” is an anatomical body site;

 

“M” is a specified month of the year;

 

“MED” means minimal erythemal dose, where one MED is equal to 200 Joules of radiation per square metre of skin;

 

“[MED cum (a,T)]” means the cumulative solar UV dose to the skin for any given anatomical body site for the person’s age at the time of the assessment;

 

“n” has the value specified in column 2 of Table 7 opposite the item in column 1 of that Table for each of the specified life activities set out in column 1:

 

Table 7—specified life activities

column 1

column 2

Service workday

1

Service weekend

2

Service recreation period one

3

Service recreation period two

4

Civilian workday

5

Civilian weekend

6

Civilian recreation period one

7

Civilian recreation period two

8

 

“PAE” means personal ambient exposure in MEDs, calculated for each and every month of a person’s life based on an estimate of a typical month during each of the five year periods between the ages of 0 and 20 years and each of the ten year periods thereafter;

 

“PAE (n,M,a)” is the numerical value calculated by the formula:

 

n-8

MAE (M,Ln) . ABFa . EFn . TRFn . ESFn . CPFn . ERFn . Wn

n-1

 

where:

 

“ABFa  is the anatomical body factor, and has the value specified in column 2 of Table 8 opposite the item in column 1 of that Table for each of the various body sites set out in column 1:

 

Table 8—body site

column 1

column 2

Face

0.15

 

“CPFn  is the clothing protection factor, and has the value assigned to a particular anatomical site proportionately according to the amount of protection provided by clothing and sun screen, ranging from a value of 1.00 for no protection to a value of 0.05 for full cover with heavy clothing for a given specified life activity in column 1 of Table 7;

 

“EFn is the exposure factor, and has the value specified in column 2 of Table 9 opposite the item in column 1 of that Table for different exposure situations set out in column 1:

 

Table 9—exposure situations

column 1

column 2

Indoor

0.10

Mainly indoor

0.20

Indoor and outdoor

0.35

Mainly outdoor

0.50

Outdoor

0.60

 

“ERFn” is the environment reflectance factor, and has the value specified in column 2 of Table 10 opposite the item in column 1 of that Table for the different environment types set out in column 1:

 

Table 10—environment types

column 1

column 2

Urban

0.95

Rural

1.00

Maritime

1.00

 

where;

 

“Urban” means a location that is either a city or a town;

 

“Rural” means a location that is bushland, pastoral, or agricultural setting;

 

“Maritime” means either on the sea, lake, major river, or directly adjacent to such a body of water;

 

“ESFn  is the environment shade factor, and has the value specified in column 2 of Table 11 opposite the item in column 1 of that Table for the different environment shade types set out in column 1:

 

Table 11—environment shade types

column 1

column 2

Dense shade

0.50

Moderate shade

0.70

Light shade

0.90

No shade

1.00

 

where:

  

“Dense shade” means a location that is predominantly under dense shade, such as jungle or dense forest;

 

“Moderate shade” means a location that is predominantly under moderate shade, such as open forest or high density housing;

 

“Light shade” means a location that is predominantly under light shade, such as lightly timbered country or low density housing;

 

“No shade”  means a location that is predominantly without shade, such as open fields, tundra, beach, or ocean;

 

“MAE(M,Ln)” is the average daily ambient exposure for month, M, in location, L, assuming a long term average cloud cover, being the value, obtained from the Table set out in Schedule 1, that is contained in the row that corresponds to the particular latitude (rounded to the nearest five degrees) and is contained in the column that corresponds to the month of the year that is the particular month under consideration, for each specified life activity;

 

“TRFn  is the terrain reflectance factor, and has the value specified in column 2 of Table 12 opposite the item in column 1 of that Table for the different terrain types set out in column 1:

 

Table 12—terrain types

column 1

column 2

Brown

1.02

Black 

1.04

Green

1.05

Open water

1.08

Sand

1.16

Snow

1.40

 

where:

 

“Black”  means a terrain predominantly of black material such as asphalt;

 

“Brown” means a terrain predominantly of bare soil, clay, or buildings;

 

“Green” means a terrain predominantly of green vegetation;

 

“Open Water” means an environment surrounded by water;

 

“Sand” means a terrain predominantly of light material such as white or yellow sand;

 

“Snow” means a terrain that is predominantly covered in snow;

 

“Wn is an estimate of the number of days in a month in which a specified life activity in column 1 of Table 7 is performed, and where, for the purposes of this definition, every month is taken to have 30.4375 days;

 

“t” is the age in months of the person for the particular specified activity;

 

“T” is the age in months of the person at the time of assessment;

 

“terminal event” means the proximate or ultimate cause of death and includes:

 

a) pneumonia;

b) respiratory failure;

c) cardiac arrest;

d) circulatory failure; or

e)                  cessation of brain function.

 

Application

9. This Instrument applies to all matters to which section 120A of the Act applies.

 

 


Schedule 1

 

Average daily MED calculated for the given month and latitude

Data assumes long-term average cloud cover

 

Latitude

January

February

March

April

May

June

July

August

September

October

November

December

85°N

0.00

0.10

0.10

0.10

0.10

1.00

1.00

0.10

0.10

0.10

0.10

0.00

80°N

0.00

0.10

0.20

1.00

2.00

3.00

3.00

2.00

0.50

0.10

0.10

0.00

75°N

0.00

0.10

0.50

2.00

3.00

5.00

5.00

3.00

1.00

0.20

0.10

0.00

70°N

0.00

0.21

0.90

2.95

5.81

7.83

8.01

5.17

1.97

0.44

0.07

0.00

65°N

0.21

0.62

1.66

4.13

7.06

9.42

9.49

6.72

3.11

1.08

0.35

0.18

60°N

0.41

1.03

2.42

5.30

8.32

11.11

11.05

8.38

4.28

1.72

0.60

0.35

55°N

0.62

1.44

3.18

6.48

9.94

12.71

12.71

10.14

5.76

2.61

0.90

0.53

50°N

0.82

1.85

3.95

7.66

11.66

14.37

14.46

12.01

7.37

3.64

1.22

0.71

45°N

1.97

3.46

5.97

9.67

13.35

16.25

15.98

14.68

9.69

5.62

2.67

1.79

40°N

3.12

5.06

7.99

11.68

15.03

18.24

17.51

17.60

12.15

7.66

4.28

2.87

35°N

4.51

7.00

10.45

14.18

17.56

20.58

19.72

19.54

14.74

9.94

6.00

4.24

30°N

6.03

9.10

13.07

16.81

20.25

23.07

22.03

21.48

17.48

12.35

7.86

5.76

25°N

8.86

12.36

16.41

19.68

22.04

22.89

21.58

21.17

18.59

14.74

10.39

8.38

20°N

11.77

15.73

19.91

22.69

23.88

22.68

21.10

20.72

19.57

17.14

12.91

11.01

15°N

14.02

17.69

20.55

21.94

21.88

19.98

19.14

19.27

18.72

17.51

14.81

13.06

10°N

16.07

19.41

20.93

21.04

19.83

17.38

17.26

17.81

17.65

17.47

16.35

14.87

 5°N

17.89

19.98

20.28

19.82

18.20

16.31

16.42

17.37

18.68

18.38

17.09

16.49

Equator

19.58

20.35

19.50

18.60

16.65

15.23

15.58

16.93

19.73

19.28

17.73

18.03

5°S

19.41

20.20

19.64

19.81

17.95

16.49

17.39

19.53

22.03

21.63

20.12

19.16

10°S

19.07

20.03

19.76

20.67

18.58

16.95

18.39

21.54

24.12

24.05

22.67

20.16

15°S

23.08

23.28

22.11

19.86

15.96

14.10

15.46

18.73

22.52

24.21

24.43

23.55

20°S

25.26

24.18

21.92

17.36

12.73

10.81

11.94

15.38

19.95

24.03

26.40

25.74

25°S

25.63

23.95

20.30

14.64

9.97

7.91

8.76

11.77

16.29

20.70

24.36

25.80

30°S

25.96

23.59

18.60

11.97

7.32

5.25

5.85

8.45

12.87

17.56

22.39

25.85

35°S

22.99

20.31

15.45

9.42

5.53

3.99

4.38

6.46

10.23

14.48

19.13

22.54

40°S

20.18

17.23

12.51

7.06

3.90

2.80

3.05

4.66

7.82

11.66

16.13

19.45

45°S

17.42

14.15

9.57

5.00

2.62

1.79

2.00

3.29

5.90

9.57

13.77

16.92

50°S

15.74

12.14

7.43

3.18

1.30

0.75

0.90

1.87

4.15

7.68

12.20

15.53

55°S

14.16

10.46

6.08

2.49

1.00

0.57

0.67

1.46

3.40

6.68

10.87

13.99

60°S

12.57

8.78

4.74

1.80

0.69

0.38

0.45

1.04

2.64

5.68

9.53

12.45

65°S

10.98

7.09

3.39

1.11

0.38

0.19

0.22

0.62

1.89

4.68

8.20

10.92

70°S

9.40

5.41

2.05

0.42

0.08

0.00

0.00

0.21

1.14

3.68

6.86

9.38

75°S

6.00

3.00

1.00

0.20

0.10

0.00

0.00

0.10

1.00

2.50

4.00

5.00

80°S

3.00

1.50

0.50

0.10

0.10

0.00

0.00

0.00

0.50

1.50

1.50

2.00

85°S

1.00

0.50

0.10

0.10

0.10

0.00

0.00

0.00

0.10

1.00

1.00

2.00

 

 

Dated this Twenty-eighth day of October 1999

 

 

The Common Seal of the    )

Repatriation Medical Authority   )

was affixed to this instrument  )

in the presence of    )

 

KEN DONALD

CHAIRMAN

 

Overview

The Statement of Principles concerning Malignant Neoplasm of the Eye (C69.0-C69.4, C69.8) was introduced under the Veterans’ Entitlements Act 1986 (the Act) to address the gap in recognising the relationship between malignant neoplasm of the eye or death from such neoplasm and relevant service rendered by veterans, members of Peacekeeping Forces, or members of the Forces. This Statement of Principles was determined by the Repatriation Medical Authority, acknowledging sound medical-scientific evidence that links these conditions with service. The policy objective is to provide a framework for assessing claims where malignant neoplasm of the eye or death from such neoplasm is connected to the circumstances of a person's service, with specific factors such as solar UV damage, HIV infection, or inability to obtain appropriate clinical management considered in the evaluation. The determination applies to all matters governed by section 120A of the Act.

Scope and Application

The Statement of Principles concerning Malignant Neoplasm of the Eye under the Veterans’ Entitlements Act 1986 applies to veterans, members of Peacekeeping Forces, and members of the Forces who have developed malignant neoplasm of the eye or have died from such a condition. This legislation pertains specifically to primary malignant neoplasms of the eye, with ICD-10-AM codes in the range C69.0 to C69.4 or C69.8, excluding soft tissue sarcoma, non-Hodgkin’s lymphoma, and Hodgkin’s disease of or affecting the eye. It encompasses conditions affecting the conjunctiva, cornea, retina, uveal tract, and eyeball, but excludes lacrimal gland and duct, orbit, optic nerve, and the skin and connective tissue of the eyelid. The Statement of Principles identifies factors that must be related to relevant service, including a solar UV damage factor ratio of at least 1.1, infection with Human Immunodeficiency Virus (HIV) before the clinical onset, or inability to obtain appropriate clinical management. This legislation extends to all matters covered by section 120A of the Act, providing a framework for assessing and compensating veterans and their dependents for service-related eye conditions.

Key Provisions

This legislative instrument, numbered 64 of 1999, pertains to a Statement of Principles concerning malignant neoplasm of the eye and death from malignant neoplasm of the eye, as determined by the Repatriation Medical Authority under the Veterans’ Entitlements Act 1986 (the Act) (section 1). Specifically, this Statement of Principles addresses malignant neoplasm of the eye, which is defined as a primary malignant neoplasm of the cells of the eye, falling within the ICD-10-AM code range C69.0 to C69.4 or C69.8, excluding conditions such as soft tissue sarcoma, non-Hodgkin’s lymphoma, and Hodgkin’s disease of or affecting the eye (section 2(b)). The eye, for the purpose of this Statement, includes the conjunctiva, cornea, retina, uveal tract, and eyeball but excludes the lacrimal gland and duct, orbit, optic nerve, and skin and connective tissue of the eyelid (section 2(b)). Under this legislative instrument, the Repatriation Medical Authority must consider whether malignant neoplasm of the eye and death from such a condition can be related to relevant service rendered by veterans, members of Peacekeeping Forces, or members of the Forces. To establish a connection between the malignant neoplasm of the eye or death from such a condition and the circumstances of a person’s relevant service, at least one of the specified factors must be related to the relevant service rendered (section 4). These factors include having a solar UV damage factor ratio of at least 1.1 before the clinical onset of malignant neoplasm of the eye, being infected with Human Immunodeficiency Virus (HIV) before the clinical onset of malignant neoplasm of the eye, or the inability to obtain appropriate clinical management for malignant neoplasm of the eye (section 5). It is noteworthy that the factor concerning the inability to obtain appropriate clinical management for malignant neoplasm of the eye applies only to the material contribution to, or aggravation of, malignant neoplasm of the eye where the condition was suffered or contracted before or during (but not arising out of) the person’s relevant service (section 6). The Act imposes obligations on the parties involved to provide necessary evidence and information to substantiate claims of malignant neoplasm of the eye or death from such a condition related to relevant service. Claimants must demonstrate that at least one of the specified factors exists and is related to their service. The Repatriation Medical Authority must review the provided evidence and determine whether a reasonable hypothesis has been raised connecting the malignant neoplasm of the eye or death from such a condition with the relevant service rendered by the claimant. Failure to comply with the requirements of this legislative instrument or providing false or misleading information may result in the denial of benefits or entitlements. Furthermore, providing false or misleading information with the intent to deceive or obtain benefits may lead to civil or criminal consequences, including fines and imprisonment, as prescribed by the relevant legislation. The specific penalties for such offences are not explicitly stated in this legislative instrument, but they would be in accordance with the general provisions of the applicable laws.

Legal classification tags

Area of Law
Veterans’ Entitlements Law
Instrument
Legislative Instrument
Concepts
Definitions & Interpretation
Licensing & Registration
Civil Penalty Provisions

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.